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Abstract: In this study we examined the glycaemic index (GI) and glycaemic load (GL) of 
a functional food product, which contains ewe-goat whey protein and carbohydrates in a 
1:1 ratio. Nine healthy volunteers, (age, 23.3 ± 3.9 years; body mass index, 24.2 ± 4.1 kg·m2; 
body fat %, 18.6 ± 10.0) randomly consumed either a reference food or amount of the test 
food both with equal carbohydrate content in two visits. In each visit, seven blood samples 
were collected; the first sample after an overnight fast and the remaining six at 15, 30, 45, 
60, 90 and 120 min after the beginning of food consumption. Plasma glucose concentration 
was measured and the GI was determined by calculation of the incremental area under the 
curve. The GL was calculated using the equation: test food GI/100 g available carbohydrates 
per test food serving. The GI of the test food was found to be 5.18 ± 3.27, while the GL  
of one test food serving was 1.09 ± 0.68. These results indicate that the tested product can 
be classified as a low GI (<55) and low GL (<10) food. Given the health benefits of low 
glycaemic response foods and whey protein consumption, the tested food could potentially 
promote health beyond basic nutrition. 
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1. Introduction 
Functional foods are defined as “foods that, by virtue of the presence of physiologically-active 
components, provide a health benefit beyond basic nutrition” [1]. As consumer interest in functional 
dietary items is increasing, there is a need to evaluate all physiologically active components and their 
role in health promotion [2,3]. Furthermore, their ability to impact metabolic parameters and chronic 
disease, such as diabetes, cardiovascular disease and cancer is of great interest to health-policy makers 
and the food industry. 
One of the food properties that may enhance health is its glycaemic response, which relates to  
its glycemic index (GI) and glycaemic load (GL) [4,5]. GI is an estimate of the glycaemic effect of 
available carbohydrate in a food on blood glucose levels compared to the effect of an equal amount of 
glucose [6]. GL relates the GI to a specific food serving. Implementation of low glycaemic index (LGI) 
and/or low glycaemic load (LGL) diets benefit metabolic profiles [4,5,7–9] and leads to prevention or 
slower progression of several types of cancer [10]. Additionally, consuming meals that result in a high 
glycaemic response may lead to transformation of metabolic pathways, increased appetite, overeating, 
and increased body mass and body fat [11]. In contrast, both short-term and long-term studies demonstrate 
that the consumption of LGI or LGL foods, in conjunction with reduced energy intake, assists weight 
and fat mass reduction [7,8,12,13]. Therefore, foods giving a low glycaemic response may have a profound 
effect in morbid conditions related to obesity. 
In this study we tested a commercially available bar made with organic ingredients. It has a 
carbohydrate:protein ratio of 1:1 and is considered as a functional product due to its ewe-goat whey 
content, which has health-enhancing properties [14–16]. Given the rapid rise in metabolic disease and 
obesity in both adults and children [17], there is a great need to better communicate the GI/GL profile 
of foods to consumers. Therefore, the objective of this study was to determine the GI and GL of  
a special carbohydrate-protein bar in a healthy population. Results may give further support to the 
health enhancing properties of this and similar products and enrich the database of GI-labeled and 
marketed functional food products. 
2. Experimental Section  
2.1. Participants 
Eleven healthy recreationally active men (n = 5) and six women (n = 6) were initially recruited. 
Two women failed to complete the experimental process due to personal reasons. Inclusion criteria 
included the absence of any clinical symptoms or chronic diseases as determined by a health 
questionnaire. Exclusion criteria included the presence of gastrointestinal disease or metabolic disease, 
medication treatment (including nutritional supplements), current pregnancy, lactation or following a 
specific diet regime. A written informed consent was provided by all participants after they had been 
informed of all risks, discomforts and benefits involved in the study. The procedures were in accordance to 
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the 1975 Helsinki declaration, and approved by the Institutional Review Board of the University of 
Thessaly, Greece. 
2.2. Anthropometric and Physiological Measurement 
Participants reported to the laboratory twice. During their first visit, following an overnight fast, 
they had their body mass, body fat and hydration level assessed using leg-to-leg bioelectrical impedance 
scales (Tanita BF 522 W, TANITA Corp., Illinois, IL, USA) while lightly dressed and barefooted. 
Standing height was measured to the nearest 0.5 cm (Stadiometer 208, Seca, Birmingham, UK). Body 
mass index was calculated using the equation weight (kg)/[height (m)]2. Waist and hip circumferences 
were obtained with measuring tape. Blood pressure was acquired via a manual sphygmomanometer; the 
lowest of three readings was recorded. Resting heart rate was recorded by short-range telemetry (Polar 
RS100, Polar Electro Oy, Kempele, Finland). Anthropometric characteristics of all participants appear 
in Table 1. 
Table 1. Baseline anthropometric and physiological characteristics of participants (Mean ± SD). 
Characteristics n = 9 
Age (years) 23.3 ± 3.9 
Height (cm) 176.4 ± 13.0 
Weight (kg) 75.8 ± 17.7 
Body Mass Index (kg/m2) 24.2 ± 4.1 
Body Fat (%) 18.6 ± 10.0 
Hydration (%) 56.3 ± 6.7 
Waist/Hip ratio 0.8 ± 0.0 
Systolic Blood Pressure (mmHg) 113.9 ± 13.4 
Diastolic Blood Pressure (mmHg) 74.2 ± 7.1 
Resting Heart Rate (beats·min−1) 71.2 ± 4.8 
2.3. Study Design 
According to recommendations by FAO/WHO [18] for the measurement of GI, participants underwent 
two different trials after overnight fasting separated by at least seven days. In the trials, they consumed 
in random order either the reference food (250 mL aqueous solution containing 50 g of glucose), or 
test food of equal carbohydrate content and 250 mL of water. At each visit, blood samples were taken 
after 12 h fasting at baseline (0 min) and at times 15, 30, 45, 60, 90 and 120 min after the consumption 
of food. Τhe consumption of the reference or test food was completed within 15 min. No other food or 
liquid intake was allowed for the next 120 min. Participants were asked to refrain from alcohol, caffeine, 
and exercise for the two days prior to each trial. 
2.4. Standard and Test Food 
The test food was an organic chocolate- orange flavored bar, which has a carbohydrate:protein:lipid 
content ratio of 2:2:1. Protein extracts used to prepare the bar derived from ewe-goat milk whey 
protein. The bar is produced in Greece and is sold under the commercial name “50/50 Feta Bar” by 
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Eatwalk Hellas. Nutritional analysis of the test food is shown in Table 2. The serving size is considered 
70 g and all participants consumed an amount of the test food (167 g) that corresponded to 50 g 
available carbohydrate content. The exact amount of the test food was determined using an analytical 
balance (Kern ALS 120-4, Balingen, Germany). An aqueous glucose solution containing 50 g of 
glucose was used as the standard food (Top Star 50, Toplabs, Portugal). 




Per 100 g Per Portion 70 g Daily Dietary Values % (70 g) 
Energy (kcal) 409.1 286.3 14.3 
Protein (g) 30.8 21.6 43.2% 
Whey protein (g) 14.3 10.01 43.2% 
Total Carbohydrate (g) 30.2 21.1 7.7% 
Sugar (g) 19.7 13.8 15.5% 
Fiber (g) 5.2 3.6 13.1% 
Fat (g) 15.6 10.9 15.9% 
Saturated Fat (g) 7.0 4.9 21.2% 
Unsaturated Fat (g) 8.6 6.0 - 
Polyols (g) 6.0 4.2 - 
Sodium × 2.5 (mg) 52 36.4 3.9% 
Potassium (mg) 27.5 19.2 - 
2.5. Blood Collection and Analyses 
A flexible catheter was inserted into an antecubital vein and blood was drawn at 0, 15, 30, 45, 60, 
90 and 120 min. Blood (7 mL) was drawn at each time point into ethylenediamine tetra-acetic acid 
(EDTA) tubes which were immediately placed on ice. Following each blood sampling, the catheter 
was flushed with 2–3 mL saline to prevent blood clotting. A portion (1–2 mL) of the blood collected 
was used to determine the parameters of the complete blood count measured by an automatic biochemical 
analyzer (Mythic 18 Orphée, Orphée Medical, Geneva, Switzerland). The remaining blood was 
centrifuged at 4 °C, 1370 g for 10 min for separation of plasma in a refrigerated centrifuge (Heraeus 
Biogigure Primo, Thermo Scientific, Waltham, MA, US). Then the collected supernatant was transferred to 
Eppendorf tubes (Eppendorf TM, Sarstedt AG & Co., Nümbrecht, Germany). The samples were stored 
at −80 °C and thawed only once before analysis. Plasma glucose concentration was determined using a 
biochemical analyzer (Clinical Chemistry Analyzer Z 1145-Zafiropoulos Diagnostica, Koropi, Greece). 
2.6. Dietary Analyses 
In order to ensure that the last meal preceding the trials did not affect glycaemic response results, 
participants were instructed to record their evening meal prior to their first trial; this food intake was 
replicated the evening before the second trial [19]. Each participant was provided with a written set of 
guidelines for monitoring dietary consumption and a record sheet for recording food intake. Diet 
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records were subsequently analyzed using the computerized nutritional analysis system DietSpeak© 
(DietSpeak Hellas, Athens, Greece). 
2.7. Calculation of GI-Statistical Analyses 
GI was calculated with the method of incremental area under the curve (iAUC) ignoring the area 
under baseline. Specifically, F:R were calculated, where F is the mean iAUC for a group of participants 
after consuming the test food and R is the mean iAUC for the same group of participants after 
consuming the reference food [18]. Then the following equation was used to determine the GI of the 
product [6,18,19]:  
GI = iAUC (50 g available carbohydrates of the test food)/iAUC (50 g carbohydrates of the 
reference food) × 100 
(1)
GL of one serving was calculated as follows:  
GL = [GI × available carbohydrate in one serving (g)]/100 (2)
Baseline values in the two trials were compared by paired t-test. p-Values were considered significant  
at p < 0.05. Results are presented as (Mean ± SD) apart from GI, GL values and Figure 1 (Mean ± SEM). 
3. Results 
Complete blood count test values obtained during the two trials are presented in Table 3. All values 
were within the normal range, indicating that the present volunteers were healthy. Fasting glucose values 
were 4.95 ± 0.26 mmol/L and 4.98 ± 0.14 mmol/L (p > 0.05) for the test and reference food trial, 
respectively. These values were within the normal range (<5.5 mmol/L blood plasma). 
Table 3. Baseline complete blood count values for individuals participating in the reference 
and test food trial (Mean ± SD). 
Complete Blood Count Variables Standard Food Test Food 
Normal 
Range 
White Blood Cells (103/μL) 6.4 ± 1.4 6.2 ± 1.0 4.0–12.0 
Lymphocytes (103/μL) 2.4 ± 0.7 2.4 ± 0.2 1.0–5.0 
Mononuclear Cells (103/μL) 0.6 ± 0.2 0.6 ± 0.1 0.1–1.0 
Granulocytes (103/μL) 3.4 ± 0.9 3.2 ± 0.9 2.0–8.0 
Lymphocytes (%) 36.7 ± 6.5 39.4 ± 6.6 25.0–50.0 
Monocytes (%) 10.3 ± 2.7 9.5 ± 1.8 2.0–10.0 
Granulocytes (%) 53.0 ± 5.8 51.1 ± 7.3 50.0–80.0 
Red Blood Cells (106/μL) 4.7 ± 0.7 4.7 ± 0.5 4.0–6.2 
Hemoglobin (g/dL) 12.9 ± 1.4 13.5 ± 1.5 11.0–18.0 
Hematocrit (%) 38.7 ± 3.3 40.1 ± 3.0 35.0–55.0 
Mean Corpuscular Volume (μm3) 84.2 ± 12.6 86.8 ± 11.0 80.0–100.0 
Average Amount of Hemoglobin in Red (Pg) 28.1 ± 4.5 29.3 ± 4.3 26.0–34.0 
Mean Corpuscular Hemoglobin Concentration (g/dL) 33.3 ± 0.9 33.7 ± 1.4 31.0–3.5 
Erythrocyte Distribution Width (%) 12.4 ± 1.4 11.9 ± 1.3 10.0–16.0 
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Table 3. Cont. 
Platelets (103/μL) 243.1 ± 34.2 232.4 ± 47.5 150–400 
Mean Platelet Volume (μm3) 8.8 ± 0.3 8.8 ± 0.3 7.0–11.0 
Platelet Count (%) 0.2 ± 0.0 0.2 ± 0.0 0.2–0.5 
Platelet Distribution Width (%) 16.1 ± 4.6 16.4 ± 4.7 10.0–18.0 
Mean total energy intake of the evening meal preceding each trial for the nine participants was  
628 ± 393.7 kcal. Mean total protein, fat and carbohydrate content of the meal were 24.8 ± 17 g,  
29.6 ± 24.8 g and 61.4 ± 38.4 g, respectively. Mean fiber content of the meal was 6.1 ± 5.4 g. 
The GI value of the test food resulting from the analyses was 5.18 ± 3.27 and the GL value was 
1.09 ± 0.68 g per 70 g serving. The glucose curves after reference and test food ingestion are shown  
in Figure 1. 
Figure 1. Plasma concentration of glucose during postprandial periods after the reference 
and test food ingestion (Mean ± SEM). 
 
4. Discussion 
The purpose of this study was to determine the glycaemic response of a special carbohydrate-protein bar 
in a healthy population. The calculated GI and GL of the test food (5.18 ± 3.27 and and 1.09 ± 0.68, 
respectively) classify it in the group of LGI/LGL food products [12,19]. This could be partly attributed 
to its functional ingredients as whey protein and fiber. Whey protein has been shown to decrease 
postprandial glycaemic response in a dose dependent manner through glucose and non-glucose dependent 
pathways [20,21]. Whey ingestion can exert insulinogenic effects postprandially, while co-ingestion with 
carbohydrates has a synergistic effect on insulin response [22]. In a study, addition of whey to a common 
meal (mashed potatoes and meatballs) reduced postprandial blood glucose excursion by 21% [22]. The 
glycaemic response of the tested food therefore could have been influenced by its high protein content, 
which was 43% of the average daily dietary value per portion. In addition the equally high proportion 
of carbohydrates in that bar may have reinforced the insulinotropic effects of whey. 
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Carbohydrates that resist digestion such as fiber may also substantially lower postprandial glycaemia 
and has been shown to reduce GI of a product or meal [5]. The presence of fiber in a food may induce 
prolonged digestion and increased colonic fermentation, which result to moderation of glycaemic 
responses postprandially [23]. High fiber content of the tested food (5.2 g, approximately 13% of the 
average daily dietary value per portion), which is equal to a medium sized fruit with skin, may also 
have contributed to its low GI. Although high fiber content reduces palatability of a product, it may 
add to the metabolic merits of a LGI/LGL diet. According to its properties the tested bar could be used 
as part of an LGI/LGL diet. Low glycaemic response diets are proposed as a means to favorably 
influence physiologic parameters implicated in conditions such as obesity, diabetes mellitus and risk of 
coronary heart disease [4,5,7–9]. A metanalysis by Livesey and colleagues [5] has shown evidence that 
fasting blood glucose is reduced following the consumption of LGI/LGL foods, especially in 
individuals with fasting blood glucose concentrations in excess of 5 mmol/L. There is increasing 
evidence to show that LGI/LGL diets have the potential to protect against diabetes type II and improve 
glycaemic profiles by reducing insulin secretion and protein glycosylation [9,24]. In contrast, 
consumption of HGI foods results in postprandial hyperglycaemia and hyperinsulinemia [11,12]. 
Therefore, a functional food product, as the one we tested, characterized by sweet taste but low 
glycaemic response could be ideally used against sweet food cravings of type I and II diabetics [25].  
It is believed that metabolic syndrome sufferers may also benefit by consumption of LGI/LGL foods as 
they can induce favorable changes in low density lipoprotein and blood triglycerides, and maintain or 
slightly improve high density lipoprotein levels [5,9]. 
Diets that produce a high glycaemic response are blamed for hyperinsulinemia, insulin resistance or 
reduced glucose tolerance, which seem to be positively correlated with increased risk of several types 
of cancer [10] and systemic inflammation [26]. In contrast, LGI/LGL food products are considered of 
superior biological and health value [5]. As obesity has become a major consideration, LGI/LGL diets 
have been suggested to promote higher fat oxidation and prolonged satiety, which may be conducive to 
body fat and body mass reduction [13,14]. Also, there is scientific evidence to support the notion that 
whey protein beneficially affects satiation and satiety [27]; therefore it may help reduce obesity and its 
co-morbidities. A single serving (70 g) of the tested bar provides 286 kilocalories (kcal), thus, it could 
be part of a weight loss plan without the side effects of other sweetened food products. 
In relation to exercise nutrition, data concerning the GI of food consumed before, after and during 
exercise are inconclusive. Most studies show that consuming LGI carbohydrate before exercise results 
in a favourable metabolic profile during exercise, but with limited positive effect on actual performance [28]. 
No research has indicated that consumption of HGI foods prior to exercise negatively affects exercise 
performance [28,29]. In a study, consumption of LGI vs. HGI carbohydrate during 24 h of recovery 
after endurance exercise resulted in 7 out of 8 participants running longer in the LGI trial when subsequent 
exercise was performed in the fasted state [30]. Authors attributed their findings to the higher rate of 
fat oxidation and a higher concentration of plasma free fatty acids observed during subsequent exercise. 
Inconclusive findings overall suggest that individuality may be more significant concerning glycaemic 
response and performance; therefore more properly designed studies should be conducted. 
The tested bar may present additional health benefits due to its whey protein content. This protein 
provides protection and/or improvement in chronic disease such as cardiovascular diseases [14], bacterial 
infections [31], cancer [32] and osteoporosis [33]. Whey protein is also rich in sulfur-containing cysteine 
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and methionine, which contribute to the enhancement of antioxidant defense through intracellular 
conversion to glutathione [14]. Its high concentration in branched-chain amino acids plays a key role 
in protein metabolism which contributes to muscle hypertrophy [34], while it may enhance exercise 
performance by reducing muscle damage [35] and incidence of overtraining [36]. A similar food product 
but with lower protein content has been previously investigated in relation to its anti-inflammatory [37] 
and antioxidant response [38] to exercise. Participants either consumed four servings of the test food or 
an isocaloric placebo before they undertook 2 h moderate intensity cycling exercise followed by a very 
intense exercise session leading to exhaustion. While performance was not affected, results indicated 
that markers of lipid peroxidation (thiobarbituric acid reactive substances) as well as pro-inflammatory 
markers (interleukin-6 and C-reactive protein) were significantly reduced in the test food trial [37,38]. 
This study, although carefully conducted is not without limitations. The number of participants may 
be characterized as limited although very close to the sample number suggested by current literature in 
order to provide useful results [19]. However, two to three times more subjects would greatly improve 
precision. Moreover, the time given to subjects to consume the bar was fifteen minutes given its reduced 
chewability compared to the glucose drink. Therefore, it is highly likely that the prolonged time of 
ingestion flattened glucose curves in both reference and test food trials [19]. Finally, a catheter was 
inserted and venous blood was taken throughout the study to avoid frequent punctures of the subject. Even 
though literature indicates [19] that glucose values might differ when venous blood is used as compared  
to capillary; we assume that blood sampling did not affect our results since the measurement of GI in 
the test and standard foods was performed utilizing venous blood. 
5. Conclusions 
The present data revealed that the tested product of 21.6 g protein and 21.1 g carbohydrates can be 
classified as LGI and LGL. Given the multiple health effects, the tested food could potentially be part 
of a health promoting diet for both patients and healthy individuals. 
Author Contributions 
AZJ, DK and YK were responsible for the study conception and study design. EM, KG, MK  
and CD acquired data. AZJ, EM, KG and MK performed the analysis. AZJ made contributions to 
interpretation of data. EM drafted the manuscript. All authors revised the manuscript critically for 
important intellectual content. All authors read and approved the final manuscript. 
Conflicts of Interest 
The authors declare no conflict of interest. 
References 
1. Diplock, A.T.; Aggett, P.J.; Ashwell, M.; Bornet, F.; Fern, E.B.; Roberfroid, M.B. Scientific 
concepts of functional foods in Europe: Concensus document. Br. J. Nutr. 1999, 81, S1–S27. 
2. Hasler, C.M.; Brown, A.C.; American Dietetic Association. Position of the American dietetic 
association: Functional foods. J. Am. Diet. Assoc. 2009, 109, 735–746. 
Nutrients 2014, 6 2248 
 
3. Mitchell, H.L. The glycemic index concept in action. Am. J. Clin. Nutr. 2008, 87, 244S–246S. 
4. Blaak, E.E.; Antoine, J.M.; Benton, D.; Björck, I.; Bozzetto, L.; Brouns, F.; Diamant, M.; Dye, L.; 
Hulshof, T.; Holst, J.J.; et al. Impact of postprandial glycaemia on health and prevention of 
disease. Obes. Rev. 2012, 13, 923–984. 
5. Livesey, G.; Taylor, R.; Hulshof. T.; Howlett, J. Glycemic response and health—A systematic 
review and meta-analysis: Relations between dietary glycemic properties and health outcomes. 
Am. J. Clin. Nutr. 2008, 87, 258S–268S. 
6. Jenkins, D.J.; Wolever, T.M.; Taylor, R.H.; Barker, H.; Fielden, H.; Baldwin, J.M.; Bowling, A.C.; 
Newman, H.C.; Jenkins, A.L.; Goff, D.V. Glycemic index of foods: A physiological basis for 
carbohydrate exchange. Am. J. Clin. Nutr. 1981, 34, 362–366. 
7. De Rougemont, A.; Normand, S.; Nazare, J.A.; Skilton, M.R.; Sothier, M.; Vinoy, S.; Laville, M. 
Beneficial effects of a 5-week low-glycaemic index regimen on weight control and cardiovascular 
risk factors in overweight non-diabetic subjects. Br. J. Nutr. 2007, 98, 1288–1298. 
8. Thomas, D.; Elliot, E.J.; Baur, L. Low glycaemic index or low glycaemic load diets for overweight 
and obesity. Cochrane Database Syst. Rev. 2007, 18, CD005105. 
9. Brand-Miller, J.C.; Hayne, S.; Petocz, P.; Colagiuri, S. Low glycemic index diets in the 
management of diabetes: A meta-analysis of randomized controlled trials. Diabetes Care 2003, 
26, 2261–2267. 
10. Gnagnarella, P.; Gandini, S.; la Vechia, C.; Maisonneuve, P. Glycemic index, glycemic load, and 
cancer risk: A meta-analysis. Am. J. Clin. Nutr. 2008, 87, 1793–1801. 
11. Roberts, S.B. High-glycemic index foods, hunger, and obesity: Is there a connection? Nutr. Rev. 
2000, 58, 163–169. 
12. Brand-Miller, J.; McMillan-Price, J.; Steinbec, K.; Caterson, I. Dietary glycemic index: Health 
implications. J. Am. Coll. Nutr. 2009, 28, 446S–449S. 
13. Brand-Miller, J.C.; Holt, S.H.; Pawlak, D.B.; McMillan, J. Glycemic index and obesity. Am. J. 
Clin. Nutr. 2002, 76, S281–S285. 
14. Marshall, K. Therapeutic applications of whey protein. Altern. Med. Rev. 2004, 9, 136–156. 
15. Madureira, A.R.; Claudia, C.I.; Gomes, A.M.P.; Pintado, M.E.; Malcata, X.F. Bovine whey 
proteins—Overview on their main biological properties. Food Res. Int. 2007, 40, 1197–1211. 
16. Moatsou, G.; Hatzinaki, A.; Samolada, M.; Anifantakis, E. Major whey proteins in ovine and goat 
acid wheys from indigenous Greek breeds. Int. Dairy J. 2005, 15, 123–131. 
17. Koutedakis, Y.; Bouziotas, C.; Flouris, A.D.; Nelson, P.N. Longitudinal modeling of adiposity in 
periadolescent Greek schoolchildren. Med. Sci. Sports Exerc. 2005, 37, 2070–2074. 
18. World Health Organization; Food and Agriculture Organization of the United Nations. Report of 
an FAO/WHO Expert Consultation on Carbohydrates: Carbohydrates in Human Nutrition; Food 
and Agriculture Organization: Rome, Italy, 1998. 
19. Brouns, F.; Bjorck, I.; Frayn, K.N.; Gibbs, A.L.; Lang, V.; Slama, G.; Wolever, T.M.S. 
Glycaemic index methodology. Nutr. Res. Rev. 2005, 18, 145–171. 
20. Nilsson, M.; Stenberg, M.; Frid, A.H.; Holst, J.J.; Björck, I.M. Glycemia and insulinemia in 
healthy subjects after lactose-equivalent meals of milk and other food proteins: The role of plasma 
amino acids and incretins. Am. J. Clin. Nutr. 2004, 80, 1246–1253. 
Nutrients 2014, 6 2249 
 
21. Gunnerud, U.J.; Ostman, E.M.; Björck, I.M. Effects of whey proteins on glycaemia and 
insulinaemia to an oral glucose load in healthy adults; a dose-response study. Eur. J. Clin. Nutr. 
2013, 67, 749–753. 
22. Frid, A.H.; Nilsson, M.; Holst, J.J.; Björck, I.M. Effect of whey on blood glucose and insulin 
responses to composite breakfast and lunch meals in type 2 diabetic subjects. Am. J. Clin. Nutr. 
2005, 82, 69–75. 
23. Venter, C.S.; Vorster, H.H.; Cummings, J.H. Effects of dietary propionate on carbohydrate and 
lipid metabolism in healthy volunteers. Am. J. Gastroenterol. 1990, 85, 549–553. 
24. Solomon, T.P.J.; Haus, J.M.; Kelly, K.R.; Cook, M.D.; Filion, J.; Rocco, M.; Kashyap, S.R.; 
Watanabe, R.M.; Barkoukis, H.; Kirwan, J.P. A low-glycemic index diet combined with exercise 
reduces insulin resistance, postprandial hyperinsulinemia, and glucose-dependent insulinotropic 
polypeptide responses in obese, prediabetic humans. Am. J. Clin. Nutr. 2010, 92, 1359–1368. 
25. Strachan, M.W.; Ewing, F.M.; Frier, B.M.; Harper, A.; Deary, I.J. Food cravings during acute 
hypoglycaemia in adults with type 1 diabetes. Physiol. Behav. 2004, 80, 675–682. 
26. Qi, L.; Hu, F.B. Dietary glycemic load, whole grains, and systemic inflammation in diabetes: The 
epidemiological evidence. Curr. Opin. Lipidol. 2007, 18, 3–8. 
27. Luhovyy, B.L.; Akhavan, T.; Anderson, G.H. Whey proteins in the regulation of food intake and 
satiety. J. Am. Coll. Nutr. 2007, 26, 704S–712S. 
28. Donaldson, C.M.; Perry, T.L.; Rose, M.C. Glycemic index and endurance performance. Int. J. 
Sport Nutr. Exerc. Metab. 2010, 20, 154–165. 
29. Jamurtas, A.Z.; Tofas, T.; Fatouros, I.; Nikolaidis, M.G.; Paschalis, V.; Yfanti, C.; Raptis, S.; 
Koutedakis, Y. The effects of low and high glycemic index foods on exercise performance and 
beta-endorphin responses. JISSN 2011, 8, doi:10.1186/1550-2783-8-15. 
30. Stevenson, E.; McComb, G.; Oram, C.; Williams, C. Improved recovery from prolonged exercise 
following the consumption of low glycemic index carbohydrate meals. Int. J. Sport Nutr. Exerc. 
Metab. 2005, 15, 333–349. 
31. Watanabe, A.; Okada, K.; Shimizu, Y.; Wakabayashi, H.; Higuchi, K.; Niiya, K.; Kuwabara, Y.; 
Yasuyama, T.; Ito, H.; Tsukishiro, T.; et al. Nutritional therapy of chronic hepatitis by whey 
protein (non-heated). J. Med. 2000, 31, 283–302. 
32. Bounous, G. Whey protein concentrate (WPC) and glutathione modulation in cancer treatment. 
Anticancer Res. 2000, 20, 4785–4792. 
33. Aoe, S.; Toba, Y.; Yamamura, J.; Kawakami, H.; Yahiro, M.; Kumegawa, M.; Itabashi, A.; 
Takada, Y. Controlled trial of the effects of milk basic protein (MBP) supplementation on bone 
metabolism in healthy adult women. Biosci. Biotechnol. Biochem. 2001, 65, 913–918. 
34. Ha, E.; Zemel, M.B. Functional properties of whey, whey components, and essential amino acids: 
Mechanisms underlying health benefits for active people. J. Nutr. Biochem. 2003, 14, 251–258. 
35. Anthony, J.C.; Anthony, T.G.; Kimball, S.R.; Jefferson, L.S. Signaling pathways involved  
in translational control of protein synthesis in skeletal muscle by leucine. J. Nutr. 2001, 131, 
856S–860S. 
  
Nutrients 2014, 6 2250 
 
36. Parry-Billings, M.; Budgett, R.; Koutedakis, Y.; Blomstrand, E.; Brooks, S.; Williams, C.;  
Calder, P.C.; Pilling, S.; Baigrie, R.; Newsholme, E.A. Plasma amino acid concentrations in the 
overtraining syndrome: Possible effects on the immune system. Med. Sci. Sports Exerc. 1992,  
24, 1353–1358. 
37. Kerasioti, E.; Kiskini, A.; Veskoukis, A.; Jamurtas, A.; Tsitsimpikou, C.; Tsatsakis, A.M.; 
Koutedakis, Y.; Stagos, D.; Kouretas, D.; Karathanos, V. Effect of special carbohydrate-protein 
cake on oxidative stress markers after exhaustive cycling in humans. Food Chem. Toxicol. 2012, 
50, 2805–2810. 
38. Kerasioti, E.; Stagos, D.; Jamurtas, A.; Kiskini, A.; Koutedakis, Y.; Goutzourelas, N.; Pournaras, S.; 
Tsatsakis, A.M.; Kouretas, D. Anti-inflammatory effects of special carbohydrate-protein cake 
after exhaustive cycling in humans. Food Chem. Toxicol. 2013, 61, 42–46. 
© 2014 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article 
distributed under the terms and conditions of the Creative Commons Attribution license 
(http://creativecommons.org/licenses/by/3.0/). 
